A personalized immunotherapeutic vaccine (Gliovac Or ERC1671) against recurrent glioblastoma multiforme (GBM)

Research output: Contribution to journal › Article › Academic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{06ffb51132ef48e0923641c68c8cf00c,

title = "A personalized immunotherapeutic vaccine (Gliovac Or ERC1671) against recurrent glioblastoma multiforme (GBM)",

author = "V.E.J.C. Schijns and D.A. Bota and A. Stathopoulos",

year = "2015",

doi = "10.4172/2168-975X.S2-006",

language = "English",

volume = "2",

pages = "2",

journal = "Brain Disorders \& Therapy",

issn = "2168-975X",

publisher = "Omics Publishing Group",

}

TY - JOUR

T1 - A personalized immunotherapeutic vaccine (Gliovac Or ERC1671) against recurrent glioblastoma multiforme (GBM)

AU - Schijns, V.E.J.C.

AU - Bota, D.A.

AU - Stathopoulos, A.

PY - 2015

Y1 - 2015

U2 - 10.4172/2168-975X.S2-006

DO - 10.4172/2168-975X.S2-006

M3 - Article

SN - 2168-975X

VL - 2

SP - 2

JO - Brain Disorders & Therapy

JF - Brain Disorders & Therapy

ER -